Literature DB >> 26938019

Altered mRNP granule dynamics in FTLD pathogenesis.

Hilary A Bowden1, Dorothee Dormann2,1,3.   

Abstract

In neurons, RNA-binding proteins (RBPs) play a key role in post-transcriptional gene regulation, for example alternative splicing, mRNA localization in neurites and local translation upon synaptic stimulation. There is increasing evidence that defective or mislocalized RBPs - and consequently altered mRNA processing - lead to neuronal dysfunction and cause neurodegeneration, including frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Cytosolic RBP aggregates containing TAR DNA-binding protein of 43 kDa (TDP-43) or fused in sarcoma (FUS) are a common hallmark of both disorders. There is mounting evidence that translationally silent mRNP granules, such as stress granules or transport granules, play an important role in the formation of these RBP aggregates. These granules are thought to be 'catalytic convertors' of RBP aggregation by providing a high local concentration of RBPs. As recently shown in vitro, RBPs that contain a so-called low-complexity domain start to 'solidify' and eventually aggregate at high protein concentrations. The same may happen in mRNP granules in vivo, leading to 'solidified' granules that lose their dynamic properties and ability to fulfill their physiological functions. This may result in a disturbed stress response, altered mRNA transport and local translation, and formation of pathological TDP-43 or FUS aggregates, all of which may contribute to neuronal dysfunction and neurodegeneration. Here, we discuss the general functional properties of these mRNP granules, how their dynamics may be disrupted in frontotemporal lobar degeneration/amyotrophic lateral sclerosis, for example by loss or gain of function of TDP-43 and FUS, and how this may contribute to the development of RBP aggregates and neurotoxicity. In this review, we discuss how dynamic mRNP granules, such as stress granules or neuronal transport granules, may be converted into pathological aggregates containing misfolded RNA-binding proteins (RBPs), such as TDP-43 and FUS. Abnormal interactions between low-complexity domains in RBPs may cause dynamic mRNP granules to solidify and become dysfunctional. This may result in a disturbed stress response, altered mRNA transport and local translation, as well as RBP aggregation, all of which may contribute to neuronal dysfunction and neurodegeneration.
© 2016 International Society for Neurochemistry.

Entities:  

Keywords:  ALS; FTLD; FUS/TLS; TDP-43; mRNP granules; stress granules

Mesh:

Substances:

Year:  2016        PMID: 26938019     DOI: 10.1111/jnc.13601

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  30 in total

Review 1.  Long-term memory consolidation: The role of RNA-binding proteins with prion-like domains.

Authors:  Indulekha P Sudhakaran; Mani Ramaswami
Journal:  RNA Biol       Date:  2016-10-11       Impact factor: 4.652

2.  Dysregulation of TDP-43 intracellular localization and early onset ALS are associated with a TARDBP S375G variant.

Authors:  Kathy Newell; Francesca Paron; Miguel Mompean; Jill Murrell; Elisa Salis; Cristiana Stuani; Gary Pattee; Maurizio Romano; Douglas Laurents; Bernardino Ghetti; Emanuele Buratti
Journal:  Brain Pathol       Date:  2018-12-27       Impact factor: 6.508

3.  FUScinating insights into motor neuron degeneration.

Authors:  Dorothee Dormann
Journal:  EMBO J       Date:  2016-04-06       Impact factor: 11.598

Review 4.  Inherited and Sporadic Amyotrophic Lateral Sclerosis and Fronto-Temporal Lobar Degenerations arising from Pathological Condensates of Phase Separating Proteins.

Authors:  Michael Fernandopulle; GuoZhen Wang; Jonathon Nixon-Abell; Seema Qamar; Varun Balaji; Ryuta Morihara; Peter H St George-Hyslop
Journal:  Hum Mol Genet       Date:  2019-11-21       Impact factor: 6.150

Review 5.  The roles of intrinsic disorder-based liquid-liquid phase transitions in the "Dr. Jekyll-Mr. Hyde" behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.

Authors:  Vladimir N Uversky
Journal:  Autophagy       Date:  2017-12-17       Impact factor: 16.016

Review 6.  C9orf72-mediated ALS and FTD: multiple pathways to disease.

Authors:  Rubika Balendra; Adrian M Isaacs
Journal:  Nat Rev Neurol       Date:  2018-09       Impact factor: 42.937

Review 7.  Post-translational Control of RNA-Binding Proteins and Disease-Related Dysregulation.

Authors:  Alejandro Velázquez-Cruz; Blanca Baños-Jaime; Antonio Díaz-Quintana; Miguel A De la Rosa; Irene Díaz-Moreno
Journal:  Front Mol Biosci       Date:  2021-04-27

8.  Axonal transport defects are a common phenotype in Drosophila models of ALS.

Authors:  Katie R Baldwin; Vinay K Godena; Victoria L Hewitt; Alexander J Whitworth
Journal:  Hum Mol Genet       Date:  2016-04-07       Impact factor: 6.150

Review 9.  Disease Mechanisms and Therapeutic Approaches in C9orf72 ALS-FTD.

Authors:  Keith Mayl; Christopher E Shaw; Youn-Bok Lee
Journal:  Biomedicines       Date:  2021-05-25

Review 10.  Synaptic dysfunction in amyotrophic lateral sclerosis/frontotemporal dementia: Therapeutic strategies and novel biomarkers.

Authors:  Karthik Krishnamurthy; Piera Pasinelli
Journal:  J Neurosci Res       Date:  2021-03-17       Impact factor: 4.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.